Predictive of IA (AUC 0.91) and progression to diabetes (AUC 0.92); identified key biomarkers such as serum ascorbate, PTPN22 polymorphism, serum glucose, ADP fibrinogen, and mannose. This evidence concerns the gene PTPN22 and diabetes mellitus.